National Notary Association Becomes Member of SAFE-BioPharma Association
2008-08-05 13:02:00
National Notary Association Becomes Member of SAFE-BioPharma Association
FT. LEE, N.J.–(EMWNews)–The National Notary Association (NNA), the nation’s
largest professional notary association, has become a member of
SAFE-BioPharma Association, the non-profit association that created and
manages the global SAFE-BioPharma™ digital
identity and signature standard for the pharmaceutical and healthcare
industries.
The NNA, which became the first SAFE-BioPharma member not directly
associated with pharmaceutical or healthcare, will train, support and
dispatch its member notaries to provide third party identity proofing
services to pharmaceutical and healthcare companies using the
SAFE-BioPharma standard.
“Creating a national infrastructure of
specially-trained notaries public who can support the rapidly expanding
use of SAFE-BioPharma digital identities is extremely important to
making pharmaceutical and healthcare operate more efficiently,”
said Mollie Shields-Uehling, president and CEO, SAFE-BioPharma
Association. The SAFE-BioPharma standard is used throughout industry to
verify and manage identities and to digitally sign electronic documents.
Every individual who qualifies to use the SAFE-BioPharma standard must
first have his or her identity properly authenticated. Among the
available options for authenticating identity is the use of a notary
public who, serving as an independent, trusted party, has a face-to-face
meeting with the person seeking to use the SAFE-BioPharma standard. In
this meeting, the notary reviews authenticating identification documents
(such as drivers’ license and passport) that
conform to specific, prescribed requirements. The in-person meeting and
document review meets the federal government’s
requirement for Level 3 identity assurance and represents strong
authentication and a high level of trust. In the United States, this
assurance level is required to remotely apply a digital signature and to
prevent legal repudiation.
“With the NNA’s
national network of trusted and proven notaries as identity proofers,
SAFE-BioPharma members have access to an in-person identity proofing
option that is unmatched in reliability and convenience. We credit
SAFE-BioPharma with having the vision to bring to the pharmaceutical and
healthcare industries the security benefits of this trusted notary
network,” said Tim Reiniger, executive
director, National Notary Association.
With hundreds of thousands of members throughout the U.S., the NNA has
created the Trusted Enrollment Agent™
program, a nationwide network of notaries public available to
organizations to authenticate the identities of individuals applying for
electronic identity credentials that authorize the sending, receiving
and handling of sensitive electronic documents.
The SAFE-BioPharma™ standard was established
by the biopharmaceutical industry to help it transform to a fully
electronic environment from inefficient paper-based business and
regulatory processes. SAFE-BioPharma provides a high level of trust
assurance for digital identities, which are uniquely bound to
corresponding digital signatures.
About SAFE-BioPharma Association
SAFE-BioPharma Association is the non-profit association that created
and manages the SAFE-BioPharma™ digital
identity and signature standard for the pharmaceutical and healthcare
industries. The SAFE-BioPharma industry standard is used to mitigate
legal, regulatory and other business risk associated with
business-to-business and business-to-regulator electronic transactions.
It facilitates interoperability by providing a secure, enforceable, and
regulatory-compliant way to verify identities of parties involved in
electronic transactions. SAFE-BioPharma’s
vision is to be a catalyst in transforming the biopharmaceutical and
healthcare communities to a fully electronic business environment by
2012. The Association’s members include Amgen
(NASDAQ: AMGN), AstraZeneca (NYSE: AZN), Bristol-Myers Squibb
(NYSE:BMY), Genzyme (NASDAQ: GENZ), GlaxoSmithKline (NYSE: GSK), Johnson
& Johnson (NYSE: JNJ), Merck (NYSE:MRK), Pfizer (NYSE: PFE), Procter &
Gamble (NYSE: PG), Roche and Sanofi-Aventis (NYSE:SNY). For more
information, visit www.safe-biopharma.org.
SAFE-BioPharma™ is a trademark of
SAFE-BioPharma Association. Any use of this trademark requires approval
from SAFE-BioPharma Association.
About the National Notary Association
Established in 1957, the NNA is the leading authority on the American
Notary office and is dedicated to educating, serving and advocating for
the nation’s 4.8 million Notaries. The NNA
imparts comprehensive notarial knowledge and understanding, promotes a
positive public perception of the Notary professional, and bolsters
consumer protection by promoting best practices. The Association’s
high-demand professional programs, services, model legislation and
groundbreaking eNotarization technology initiatives help Notaries
advance their careers and serve the American public with the highest
level of professionalism and ethics. To learn more, visit www.nationalnotary.org.
Trusted Enrollment Agent™ is a trademark
of the National Notary Association. Any use of this trademark requires
approval from the National Notary Association.
SAFE-BioPharma Association 801-860-9977 |
|
Major Newsire & Press Release Distribution with Basic Starting at only $19 and Complete OTCBB / Financial Distribution only $89
Get Unlimited Organic Website Traffic to your Website
TheNFG.com now offers Organic Lead Generation & Traffic Solutions